MARCON, LUISA
MARCON, LUISA
Dipartimento di Medicina Molecolare - DMM
A comparison of the genetic and biological features of human and non-human immunodeficiency lentiviruses
1991 Marcon, Luisa; N., Hattori; R. C., Gallo; G., Franchini
A competitive enzyme-linked immunosorbent assay (ELISA) for the soluble human interleukin-2 receptor (IL-2R, Tac peptide)
1988 Goldestein, A; Marcon, Luisa; B. R., Cullen; D. L., Nelson
An analysis of soluble interleukin-2 receptors in human neoplastic disorders
1987 Nelson, D. L.; D. K., Wagner; Marcon, Luisa; C. C., Kurman; M. E., Fritz; J. M., Crisman; L., Casabo; L. A., Rubin
CD4-independent binding of S1V gpl20 to rhesus CCrS.
1997 Martin, K. A.; Wyatt, R.; Choe, H.; Farzan, M.; Marcon, Luisa; Robinson, J.; Gerard, C.; Sodroski, J.; Gerard, N. P.
Developing an epitope-driven tuberculosis (TB) vaccine
2005 DE GROOT, As; Mcmurry, J; Marcon, Luisa; Franco, J; Rivera, D; Kutzler, M; Weiner, D; Martin, B.
Dispensable role of the human immunodeficiency virus type 2 vpx protein in viral replication
1991 Marcon, Luisa; F., Michaels; N., Hattori; K., Fargnoli; R. C., Gallo; G., Franchini
Effects of soluble CD4 on simian immunodeficiency virus infection of CD4 positive and CD4 negative cells.
1999 Schenten, D.; Marcon, Luisa; Karlsson, G.; Parolin, MARIA CRISTINA; Kodama, T.; Gerard, N.; Sodroski, J.
Elevated levels of soluble interleukin-2 receptors in sera and bronchoalveolar lavage fluids in active sarcoidosis
1988 Lawrence, E. C.; K. P., Brosseau; M. B., Berger; C. C., Kurman; Marcon, Luisa; D. L., Nelson
Elevated levels of soluble interleukin-2 receptors in multiple sclerosis
1988 Greenberg, S. J.; Marcon, Luisa; B. J., Hurwitz; T. A., Waldmann; D. L., Nelson
Elevated serum levels of soluble Tac peptide in patients with adult T-cell leukemia and correlation with clinical status during chemotherapy
1988 Marcon, Luisa; L. A., Rubin; C. C., Kurman; M. E., Fritz; D. L., Longo; T., Uchiyama; D. L., Nelson
Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine
2004 DE GROOT, As; Bishop, Ea; Khan, B; Lally, M; Marcon, Luisa; Franco, J; Mayer, Kh; Carpenter, Cc; Martin, W.
Genetics and biology of human retroviruses
1989 Marcon, Luisa; G., Franchini
Gp120-independent fusion mediated by the human immunodeficiency virus type 1 gp41 envelope glycoprotein: a reassessment
1994 Marcon, Luisa; J., Sodroski
High degree of sensitivity of the simian immunodeficiency virus (S1V mac) envelope glycoprotein subunit association to amino acid changes in the gp-41 ectodomain.
1997 Marcon, Luisa; Sodroski, J.
HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment
2003 Perno, Cf; Cenci, A; Piro, C; D'Arrigo, R; Marcon, Luisa; CECCHERINI SILBERSTEIN, F; ASCOLI MARCHETTI, F; Calio, R; Antinori, A.
HIV vaccine development by computer assisted design: the GAIA vaccine
2005 DE GROOT, As; Marcon, Luisa; Bishop, Ea; Rivera, D; Kutzler, M; Weiner, Db; Martin, W.
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure
2004 CECCHERINI SILBERSTEIN, F; Erba, F; Gago, F; Bertoli, A; Forbici, F; Bellocchi, Mc; Gori, C; D'Arrigo, R; Marcon, Luisa; Balotta, C; Antinori, A; Monforte, Ad; Perno, Cf
Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer
1990 URBA W., J; R. G., Steis; D. L., Longo; W. C., Kopp; A. E., Maluish; Marcon, Luisa; D. L., Nelson; H. C., Stevenson; J. W., Clark
In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients
1989 Beaurain, G; C., Naret; Marcon, Luisa; G., Grateau; T., Drueke; P., Urena; D. L., Nelson; J. F., Bach; L., Chatenoud
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages.
2005 Aquaro, S; Svicher, V; Ceccherini Silberstein, F; Cenci, A; Marcuccilli, F; Giannella, S; Marcon, Luisa; Caliò, R; Balzarini, J; Perno, Cf